Avid Bioservices Inc buy Quitte
Start price
15.10.15
/
50%
€6.76
Target price
15.04.16
€7.70
Performance (%)
-64.12%
End price
15.04.16
€2.42
Summary
This prediction ended on 15.04.16 with a price of €2.42. Massive losses of -64.12% were the result for the BUY prediction by Quitte. Quitte has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Avid Bioservices Inc | - | - | - | - |
| iShares Core DAX® | 1,72 % | 3,37 % | 5,89 % | 52,38 % |
| iShares Nasdaq 100 | -4,56 % | -4,24 % | 21,39 % | 72,45 % |
| iShares Nikkei 225® | -7,12 % | -11,87 % | 42,36 % | 57,58 % |
| iShares S&P 500 | -0,89 % | 1,69 % | 19,49 % | 62,15 % |
Comments by Quitte for this prediction
In the thread Avid Bioservices Inc diskutieren
aussichtsreich
AstraZeneca and Peregrine Pharmaceuticals Expand Ongoing Immuno-Oncology Collaboration to Include Phase II Lung Cancer Combination Clinical Trial
By GlobeNewswire, October 15, 2015, 08:05:00 AM EDT
Read more: http://www.nasdaq.com/press-release/astrazeneca-and-peregrine-pharmaceuticals-expand-ongoing-immunooncology-collaboration-to-include-20151015-00403#ixzz3oeFAlads
Quitte stimmt am 15.10.2015 dem Sell-Crowdsentiment mit dem Kursziel 0.61€ nicht zu.
(Laufzeit überschritten)
Stopped prediction by Quitte for Avid Bioservices Inc
Avid Bioservices Inc
Start price
Target price
Perf. (%)
€8.05
03.12.20
03.12.20
€9.00
03.12.21
03.12.21
200.62%
04.12.21
04.12.21
Avid Bioservices Inc
Start price
Target price
Perf. (%)
€1.90
12.12.16
12.12.16
€3.97
28.05.18
28.05.18
60.89%
28.05.18
28.05.18
Avid Bioservices Inc
Start price
Target price
Perf. (%)
€2.57
20.04.16
20.04.16
€3.79
20.10.16
20.10.16
-16.93%
20.10.16
20.10.16
Avid Bioservices Inc
Start price
Target price
Perf. (%)
€10.67
09.03.15
09.03.15
€12.95
09.09.15
09.09.15
-31.50%
09.09.15
09.09.15